Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel

Introduction: Praziquantel (PZQ) is the only commercially available drug for schistosomiasis. The current shortage of alternative effective drugs and the lack of successful preventive measures enhance its value. The increase in the prevalence of PZQ resistance under sustained drug pressure is, there...

Full description

Bibliographic Details
Main Authors: Eglal I. Amer, Iman Fathy Abou-El-Naga, Laila M. Boulos, Heba S. Ramadan, Salwa S. Younis
Format: Article
Language:English
Published: Instituto Nacional de Salud 2022-03-01
Series:Biomédica: revista del Instituto Nacional de Salud
Subjects:
schistosoma mansoni
drug resistance
liposomes
praziquantel
Online Access:https://revistabiomedica.org/index.php/biomedica/article/view/5913

Internet

https://revistabiomedica.org/index.php/biomedica/article/view/5913

Similar Items